The effect of memantine and levodopa/carbidopa on the responses of phrenic nerve-diaphragm preparations from aged rats.
Alzheimer's dementia (AD) and Parkinsonism are common in geriatric patients. Skeletal muscles are important for proper function of aging animals and humans. This study focuses on the influence of memantine (used in moderate to severe AD) and levodopa/carbidopa (LD/CD) (a cornerstone of Parkinson's disease treatment) on responses of isolated phrenic nerve-diaphragms (IPNDs) of aged male rats. Of 100 aged male albino rats, 20 were untreated to study the in vitro effects of memantine and LD/CD on IPNDs and 80 were divided into groups 1 (control), 2 (oral memantine, 1.5 mg/kg/d), 3 (twice daily intraperitoneal LD/CD, 25/2.5 mg/kg), and 4 (both drugs). After three weeks-treatment the animals were sacrificed. Ten rats from each group were used to harvest IPNDs to study the effect of gallamine and 10 rats to measure nAchR (nicotinic acetylcholine receptor) alpha subunit mRNA by PCR. The heights of indirectly elicited contractions were 63.1+/-4.6, 41.5+/-4.5, 70.6+/-4.7, and 53.9+/-3.3 mm for groups 1-4, respectively, and all differences were statistically significant (p<0.05). Memantine caused a leftward shift of the gallamine concentration-response curve and LD/CD a rightward shift. Reversal of neuromuscular block required larger neostigmine concentrations in the memantine group and smaller concentrations in the LD/CD group. In vitro, memantine inhibited diaphragmatic responses to indirect stimulation. Values of nAchR alpha subunit mRNA (microg/dl) were 0.7+/-0.16 (control), 0.13+/-0.11 (memantine), 2.3+/-0.94 (LD/CD), and 1.18+/-0.71 (both drugs) (p<0.05). Memantine inhibits neuromuscular transmission in vitro and with in vivo treatment. LD/CD treatment enhances neuromuscular transmission. Clinical implications need further investigation.